What The Papers Say: Probiotic effect on reducing eczema risk in particular genotypes

Differential modification of genetic susceptibility to childhood eczema by two probiotics. In a double-blind, randomized, placebo-controlled birth cohort, we have recently shown a beneficial effect of Lactobacillus rhamnosus HN001 (HN001) for the prevention of eczema in children through to 6 years of age but no effect of Bifidobacterium animalis subsp lactis HN019 (HN019).

To read more about this article, please follow this link to the Wiley Online website.

See more eczema-related news headlines on What The Papers Say.